Janney Montgomery Scott LLC Janux Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

  • $33.6 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
BUY
$5.85 - $11.7 $301,555 - $603,111
51,548 New
51,548 $553,000
Q4 2021

Jan 27, 2022
SELL
$15.44 - $27.32 $630,878 - $1.12 Million
-40,860 Closed
0 $0
Q3 2021

Oct 29, 2021
BUY
$20.7 - $34.69 $845,802 - $1.42 Million
40,860 New
40,860 $884,000

Others Institutions Holding JANX

# of Institutions
123
Shares Held
25.3M
Call Options Held
92K
Put Options Held
161K
View Full List

About Janux Therapeutics, Inc.

JANX Quotes by TradingView
  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $1.75B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email